Fatal Interaction between Clarithromycin and Colchicine in Patients with Renal Insufficiency: A Retrospective Study
Open Access
- 1 August 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (3) , 291-300
Abstract
Background. Clarithromycin is frequently used to treat community-acquired pneumonia in elderly persons. Like erythromycin, it may interact with otherKeywords
This publication has 33 references indexed in Scilit:
- Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin–clarithromycin interactionBritish Journal of Clinical Pharmacology, 2003
- Drug–drug interaction mediated by inhibition and induction of P-glycoproteinAdvanced Drug Delivery Reviews, 2003
- Macrolide – induced clinically relevant drug interactions with cytochrome P‐450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycinBritish Journal of Clinical Pharmacology, 2000
- Reversal of Anticancer Drug Resistance by Macrolide Antibiotics in Vitro and in VivoClinical and Experimental Pharmacology and Physiology, 2000
- Practice Guidelines for the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2000
- Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 InhibitionClinical Pharmacokinetics, 2000
- IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3AAnnual Review of Pharmacology and Toxicology, 1998
- Markedly altered colchicine kinetics in a fatal intoxication: Examination of contributing factorsHuman & Experimental Toxicology, 1996
- La colchicine: données récentes sur sa pharmacocinétique et sa pharmacologie cliniqueLa Revue de Médecine Interne, 1995
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987